Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05509127Phase 1Active, not recruiting
Phase 1, randomised trial (2 arms), sponsored by Cairo University. Primary endpoint: Change in Marginal adaptation at 24 months. Started Jan 2023; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05509127.